reference/31581355

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31581355

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, N.I.H., Intramural\|Research Support, Non-U.S. Gov't
endingPage	953
issn	0031-6970 1432-1041
issueIdentifier	9
pageRange	947-953
publicationName	European Journal of Clinical Pharmacology
startingPage	947
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_969ccf6fe026f2f48265f62ea5c814c6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_36707675000f23e408d21e3590130d5d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_91378c6141e7a6ac95cc6d392562c090 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8b2d8dde0740e549f6ac1b0f98fe45fc http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e57d38c62c6f36b1e9947dbebd089e0a
bibliographicCitation	Joy MS, Dornbrook-Lavender K, Blaisdell J, Hilliard T, Boyette T, Hu Y, Hogan SL, Candiani C, Falk RJ, Goldstein JA. CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases. European Journal of Clinical Pharmacology. 2009 Aug 11;65(9):947–53. doi: 10.1007/s00228-009-0707-7.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fe5ebb1ff91b7f1970bd8ced5ebd78b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7836c6948cdbb0cdbd7450f59df6558 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cb851378fce5ee82a6d148e7eb00e95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f0eefa72b2f259bd578d1b23df6ec6d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c2ae2ea0a76d83c4214b7736ab8cf84 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f338199cee7a69b0ed83e3f98d9805ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2e65d104b54065d3351aec11f8ef616 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2baf2b862137377fb80018f6f30de7c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_559b3fa2a989088c9b58469dec4daf41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fefab8ec594bdfe96e67e8ade3ebf317
date	2009-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/19669737 https://doi.org/10.1007/s00228-009-0707-7 https://pubmed.ncbi.nlm.nih.gov/PMC2901912
isPartOf	https://portal.issn.org/resource/ISSN/1432-1041 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3612 https://portal.issn.org/resource/ISSN/0031-6970
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases
discusses	http://id.nlm.nih.gov/mesh/M0001456 http://id.nlm.nih.gov/mesh/M0590597 http://id.nlm.nih.gov/mesh/M0029400 http://id.nlm.nih.gov/mesh/M0456879 http://id.nlm.nih.gov/mesh/M0001774 http://id.nlm.nih.gov/mesh/M0073495
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8989 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.14.14.1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10922 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_61f7a5e5e1b7c9be084045f167e8a8b7 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c25c5bef0fa0efbec10a882f149a99d6

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1559 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29277 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128961263

Total number of triples: 53.